Form 8-K - Current report:
SEC Accession No. 0001193125-18-338026
Filing Date
2018-11-29
Accepted
2018-11-29 16:05:38
Documents
7
Period of Report
2018-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d660696d8k.htm 8-K 21581
2 EX-1.1 d660696dex11.htm EX-1.1 206712
3 EX-5.1 d660696dex51.htm EX-5.1 60919
4 EX-99.1 d660696dex991.htm EX-99.1 9557
5 EX-99.2 d660696dex992.htm EX-99.2 10125
6 GRAPHIC g660696g1128002356166.jpg GRAPHIC 5365
7 GRAPHIC g660696g1128002804343.jpg GRAPHIC 5365
  Complete submission text file 0001193125-18-338026.txt   325415
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 181208552
SIC: 2834 Pharmaceutical Preparations